Cari Gallman insider trades
Open-market stock purchases and sales by Cari Gallman, EVP, General Counsel at Bristol Myers Squibb Co, from SEC Form 4 filings since Oct 2, 2023.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 1, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | $35.5K |
| Aug 1, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | $25K |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | $23.8K |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Sold (not open market) | $81.4K |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Mar 10, 2026 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
| Oct 2, 2025 | BMY Bristol Myers Squibb Co | Sold (not open market) | $107K |
| Oct 2, 2025 | BMY Bristol Myers Squibb Co | Bought (not open market) | — |
Companies traded
- BMY Bristol Myers Squibb Co: other filings, last Aug 1, 2026